Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies
Immuno-Oncology Insights 2022; 3(9), 401–407
DOI: 10.18609/ioi.2022.043
Published: 14 October 2022
Viewpoint
Mads Hald Andersen
“Mapping the cell types and molecules
present in the inimical tumor milieu will
support the development of more effective
IMVs and teach us how best to combine the
current available options.”